There are various patented biologics available in the market, but at a cost much higher that is inaccessible to general population. This directed the need for biosimilars market. There is a need for complex infrastructure in the development of biosimilar and lengthy process of clinical trial and approval are the major challenges faced by biosimilar pipeline analysis market.
Restraints
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients